95828-47-0 ([8,8'-双-2H-呋喃并[3,2-b]萘并[2,3-d]吡喃]-2,2',6,6',11,11'-己酮,3,3',3'a,3a,5,5',11'b,11b-八氢-10,10'-二羟基-5,5'-二甲基-(3'aS,3aS,5S,5'S,11'bS,11bS)-,[8,8'-Bi-2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone,3,3',3'a,3a,5,5',11'b,11b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-,(3'aS,3aS,5S,5'S,11'bS,11bS)-)

CAS号:
95828-47-0
中文名称:
[8,8'-双-2H-呋喃并[3,2-b]萘并[2,3-d]吡喃]-2,2',6,6',11,11'-己酮,3,3',3'a,3a,5,5',11'b,11b-八氢-10,10'-二羟基-5,5'-二甲基-(3'aS,3aS,5S,5'S,11'bS,11bS)-
英文名称:
[8,8'-Bi-2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone,3,3',3'a,3a,5,5',11'b,11b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-,(3'aS,3aS,5S,5'S,11'bS,11bS)-
分子式:
C32H22O12
分子量:
598.509890079498

[8,8'-双-2H-呋喃并[3,2-b]萘并[2,3-d]吡喃]-2,2',6,6',11,11'-己酮,3,3',3'a,3a,5,5',11'b,11b-八氢-10,10'-二羟基-5,5'-二甲基-(3'aS,3aS,5S,5'S,11'bS,11bS)-(95828-47-0)名称与标识符

名称

英文别名:
[8,8'-Bi-2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone,3,3',3'a,3a,5,5',11'b,11b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-,(3'aS,3aS,5S,5'S,11'bS,11bS)-;[8,8'-Bi-2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone,3,3',3'a,3a,5,5',11'b,11b-octahydro-10,10'-dihydroxy-5,5';crisamicin A;CRS-A;95828-47-0;Q27282289;(8,8'-BI-2H-FURO(3,2-B)NAPHTHO(2,3-D)PYRAN)-2,2',6,6',11,11'-HEXONE, 3,3',3A,3'A,5,5',11B,11'B-OCTAHYDRO-10,10'-DIHYDROXY-5,5'-DIMETHYL-, (3AS-(3A.ALPHA.,5.ALPHA.,8(3AR*,5R*,11BR*),11B.ALPHA.))-;(8,8'-BI-2H-FURO(3,2-B)NAPHTHO(2,3-D)PYRAN)-2,2',6,6',11,11'-HEXONE, 3,3',3A,3'A,5,5',11B,11'B-OCTAHYDRO-10,10'-DIHYDROXY-5,5'-DIMETHYL-, (3AS,3'AS,5S,5'S,11BS,11'BS)-;(8,8'-Bi-2H-furo(3,2-b)naphtho(2,3-d)pyran)-2,2',6,6'11,11'-hexone, 3,3',3a,3'a,5,5',11b,11'b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-, (3aS-(3aalpha,5alpha,8(3aR*,5R*,11bR*),11balpha))-;KJ7654W82V;(11S,15S,17S)-7-hydroxy-5-[(11S,15S,17S)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione;UNII-KJ7654W82V;

标识符

InChIKey:
IPAXVRZEFNMCLP-GJPLRXPFSA-N
Inchi:
1S/C32H22O12/c1-9-21-25(31-17(41-9)7-19(35)43-31)29(39)23-13(27(21)37)3-11(5-15(23)33)12-4-14-24(16(34)6-12)30(40)26-22(28(14)38)10(2)42-18-8-20(36)44-32(18)26/h3-6,9-10,17-18,31-34H,7-8H2,1-2H3/t9-,10-,17-,18-,31+,32+/m0/s1
SMILES:
O1[C@@H](C)C2C(C3C=C(C=C(C=3C(C=2[C@H]2[C@@H]1CC(=O)O2)=O)O)C1C=C(C2=C(C=1)C(C1[C@H](C)O[C@H]3CC(=O)O[C@H]3C=1C2=O)=O)O)=O

[8,8'-双-2H-呋喃并[3,2-b]萘并[2,3-d]吡喃]-2,2',6,6',11,11'-己酮,3,3',3'a,3a,5,5',11'b,11b-八氢-10,10'-二羟基-5,5'-二甲基-(3'aS,3aS,5S,5'S,11'bS,11bS)-(95828-47-0)物化性质

计算特性

  • 精确分子量 : 598.11112613g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 12
  • 可旋转化学键数量 : 1
  • 同位素质量 : 598.11112613g/mol
  • 重原子数量 : 44
  • 复杂度 : 1380
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 6
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.7
  • 拓扑分子极性表面积 : 180Ų

[8,8'-双-2H-呋喃并[3,2-b]萘并[2,3-d]吡喃]-2,2',6,6',11,11'-己酮,3,3',3'a,3a,5,5',11'b,11b-八氢-10,10'-二羟基-5,5'-二甲基-(3'aS,3aS,5S,5'S,11'bS,11bS)-(95828-47-0)相关文献